What's New

Last Posted: Mar 07, 2023

• Machine Learning for Better Prognostic Stratification and Driver Gene Identification Using Somatic Copy Number Variations in Anaplastic Oligodendroglioma.
  Rosenberg Shai, et al. The oncologist 2018 0 (12) 1500-1510
• Clinical significance of the 2016 WHO classification in Japanese patients with gliomas.
  Iuchi Toshihiko, et al. Brain tumor pathology 2018 0 (2) 71-80
• Molecular biomarkers and integrated pathological diagnosis in the reclassification of gliomas.
  Ruiz María Fernanda, et al. Molecular and clinical oncology 2021 0 (2) 150
• Correlation of histology and molecular genetic analysis of 1p, 19q, 10q, TP53, EGFR, CDK4, and CDKN2A in 91 astrocytic and oligodendroglial tumors.
  Ueki Keisuke, et al. Clinical cancer research : an official journal of the American Association for Cancer Research 2002 0 (1) 196-201
• Infrequent RAS mutation is not associated with specific histological phenotype in gliomas.
  Makino Yasuhide, et al. BMC cancer 2021 9 (1) 1025
• Additional genetic alterations in BRAF-mutant gliomas correlate with histologic diagnoses.
  Dono Antonio et al. Journal of neuro-oncology 2020 Oct
• Genetic landscape of extreme responders with anaplastic oligodendroglioma.
  Holdhoff Matthias, et al. Oncotarget 2017 5 (22) 35523-35531
• Effects of the functional HOTAIR rs920778 and rs12826786 genetic variants in glioma susceptibility and patient prognosis.
  Xavier-Magalhães Ana, et al. Journal of neuro-oncology 2017 1
• The Correlation Between 1p/19q Codeletion, IDH1 Mutation, p53 Overexpression and Their Prognostic Roles in 41 Turkish Anaplastic Oligodendroglioma Patients.
  Hacisalihoglu Payam, et al. Turkish neurosurgery 2016 8
• Clinical utility and treatment outcome of comprehensive genomic profiling in high grade glioma patients.
  Blumenthal Deborah T et al. Journal of neuro-oncology 2016 Aug
• Prevalence of IDH1/2 Mutations in Different Subtypes of Glioma in the North-East Population of Morocco.
  Senhaji Nadia, et al. Asian Pacific journal of cancer prevention : APJCP 2016 0 (5) 2649-53
• Prognostic significance of histomolecular subgroups of adult anaplastic (WHO Grade III) gliomas: applying the 'integrated' diagnosis approach.
  Rajmohan K S, et al. Journal of clinical pathology 2016 1
• Co-deletion of 1p/19q as Prognostic and Predictive Biomarker for Patients in West Bohemia with Anaplastic Oligodendroglioma.
  Polivka Jiri, et al. Anticancer research 2016 1 (1) 471-6
• Molecular classification of anaplastic oligodendroglioma using next-generation sequencing: a report of the prospective randomized EORTC Brain Tumor Group 26951 phase III trial.
  Dubbink Hendrikus J, et al. Neuro-oncology 2015 9
• Molecular investigation of isocitrate dehydrogenase gene (IDH) mutations in gliomas: first report of IDH2 mutations in Indian patients.
  Das Bibhu Ranjan, et al. Asian Pacific journal of cancer prevention : APJCP 2013 0 (12) 7261-4
• Correlation of IDH1/2 mutation with clinicopathologic factors and prognosis in anaplastic gliomas: a report of 203 patients from China.
  Zhang Chuan-Bao, et al. Journal of cancer research and clinical oncology 2014 1 (1) 45-51
• Combining two biomarkers, IDH1/2 mutations and 1p/19q codeletion, to stratify anaplastic oligodendroglioma in three groups: a single-center experience.
  Frenel J S, et al. Journal of neuro-oncology 2013 8 (1) 85-91
• 1p/19q codeletion and IDH1/2 mutation identified a subtype of anaplastic oligoastrocytomas with prognosis as favorable as anaplastic oligodendrogliomas.
  Jiang H, et al. Neuro-oncology 2013 3
• Anaplastic oligodendroglioma
  From NCATS Genetic and Rare Diseases Information Center
• Glutathione S-transferase polymorphisms and survival in primary malignant glioma.
  Okcu MF, et al. Clinical cancer research : an official journal of the American Association for Cancer Research 2004 4 (8) 2618-25

More